跳至主要内容
临床试验/NCT06532188
NCT06532188尚未招募不适用

Efficacy of Hypno-ear-acupuncture on Insomnia in Advanced Cancer Patients: a Randomized Clinical Trial

Medical University of Graz2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20
试验地点
2
主要终点
Richards-Campbell Sleep Questionnaire (RCSQ)

研究概览

简要总结

This randomized controlled trial aims to test if a combination of medical hypnosis and ear acupuncture improves sleep quality in patients with advanced cancer during a hospital stay in a palliative care unit.

Patients submitted to our palliative care unit will receive a medical hypnosis and ear acupuncture on the second day of their stay. Sleep quality will be measured using validated patient-reported outcome measures at baseline and after 7 days. Additionally, the use of sleep medication will be documented as a secondary outcome.

The intervention will be compared to a sham medical hypnosis and ear acupuncture to see if the effect of the true intervention has a unique effect.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • histologically confirmed cancer
  • RCSQ total score <25mm
  • ability to read and understand the questionnaires
  • ability to give informed consent

排除标准

  • pregnancy
  • language barrier (non German)
  • inability to give informed consent
  • hypacusis
  • radiographical verified brain metastases
  • diagnosed psychosis

结局指标

主要结局

Richards-Campbell Sleep Questionnaire (RCSQ)

时间窗: Baseline and after seven days

Change in Patient-reported outcome measure assessing the sleep quality on five sleep related items using a visual analoge scale Range: 0-100mm (Visual Analog Scale) Domains/items: 5 (Sleep depth, Sleep latency, Awakenings from sleep, Ability to return to sleep, Sleep quality) Total score: mean score of all 5 domains (0-100) Interpretation: higher scores reflect better sleep quality

次要结局

  • Use of additional medication(From baseline to end of study (total seven days))
  • Edmonton symptom assessment scale (ESAS)(Baseline and after seven days)
  • Patient health questionnaire 9 (PHQ-9)(Baseline and after seven days)

研究者

发起方
Medical University of Graz
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验